HomeCompareDUFRY vs PFE

DUFRY vs PFE: Dividend Comparison 2026

DUFRY yields 1.61% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $27.6K in total portfolio value· pulled ahead in Year 9
10 years
DUFRY
DUFRY
● Live price
1.61%
Share price
$5.96
Annual div
$0.10
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.0K
Annual income
$178.30
Full DUFRY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — DUFRY vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDUFRYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DUFRY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DUFRY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DUFRY
Annual income on $10K today (after 15% tax)
$136.57/yr
After 10yr DRIP, annual income (after tax)
$151.56/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,168.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DUFRY + PFE for your $10,000?

DUFRY: 50%PFE: 50%
100% PFE50/50100% DUFRY
Portfolio after 10yr
$35.8K
Annual income
$13,218.51/yr
Blended yield
36.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

DUFRY
Analyst Ratings
1
Buy
1
Sell
Consensus: Buy
Altman Z
1.4
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DUFRY buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDUFRYPFE
Forward yield1.61%6.13%
Annual dividend / share$0.10$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$22.0K$49.6K
Annual income after 10y$178.30$26,258.71
Total dividends collected$1.7K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: DUFRY vs PFE ($10,000, DRIP)

YearDUFRY PortfolioDUFRY Income/yrPFE PortfolioPFE Income/yrGap
1$10,861$160.68$9,153$693.39+$1.7KDUFRY
2$11,784$163.09$8,593$849.25+$3.2KDUFRY
3$12,774$165.38$8,336$1,066.78+$4.4KDUFRY
4$13,836$167.55$8,437$1,384.80+$5.4KDUFRY
5$14,974$169.60$9,013$1,875.40+$6.0KDUFRY
6$16,194$171.54$10,306$2,680.72+$5.9KDUFRY
7$17,501$173.38$12,820$4,101.38+$4.7KDUFRY
8$18,901$175.12$17,673$6,826.70+$1.2KDUFRY
9← crossover$20,401$176.75$27,543$12,591.86$7.1KPFE
10$22,007$178.30$49,560$26,258.71$27.6KPFE

DUFRY vs PFE: Complete Analysis 2026

DUFRYStock

Avolta AG operates as a travel retailer. The company's retail brands include general travel retail shops under the Dufry, World Duty Free, Nuance, Hellenic Duty Free, Colombian Emeralds, Duty Free Uruguay, Hudson, Duty Free Shop Argentina, RegStaer, Autogrill, Hellenic Duty Free, HMSHost, and World Duty Free brands; Dufry shopping stores; brand boutiques; convenience stores primarily under the Hudson brand; and specialized shops and theme stores. It offers perfumes and cosmetics, food and confectionery, wines and spirits, watches and jewelry, fashion and leather, tobacco goods, souvenirs, electronics, soft drinks, packaged food, travel accessories, personal items, sunglasses, destination merchandise, and other products, as well as newspapers, magazines, and books. It operates duty-free and duty-paid shops located at airports, cruise lines, seaports, railway stations, and downtown tourist areas worldwide. The company was formerly known as Dufry AG and changed its name to Avolta AG in November 2023. The company was incorporated in 1865 and is headquartered in Basel, Switzerland.

Full DUFRY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this DUFRY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DUFRY vs SCHDDUFRY vs JEPIDUFRY vs ODUFRY vs KODUFRY vs MAINDUFRY vs JNJDUFRY vs MRKDUFRY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.